# Single & Multiple Ascending Dose Study of SAR443820 in Healthy Adult Participants

> **NCT05795907** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 84 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis (Healthy Volunteers)

## Interventions

- **DRUG:** SAR443820
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05795907
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-30
- **Primary completion:** 2021-07-20
- **Final completion:** 2021-07-20
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2023-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05795907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05795907, "Single & Multiple Ascending Dose Study of SAR443820 in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05795907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*